During the past decade, Xuzhou Infectious Disease Hospital conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Xuzhou Infectious Disease Hospital" are "COVID-19" (1 trials), "Carcinoma, Hepatocellular" (1 trials), "Multidrug Resistant Tuberculosis" (1 trials) and "Pulmonary Tuberculosis" (1 trials). Many other conditions were trialed in "Xuzhou Infectious Disease Hospital" in a lesser frequency.

Most popular intervention types in "Xuzhou Infectious Disease Hospital" are "Biological" (1 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "Double dosage inactivated vaccine" (1 trials), "PZA sensitivity guided ultra-short all Oral Regimen" (1 trials), "Standard dosage inactivated vaccine" (1 trials) and "Standardized Shorter Regimen" (1 trials). Other intervention names were less common.

The vast majority of trials in "Xuzhou Infectious Disease Hospital" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Xuzhou Infectious Disease Hospital". undefined are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Xuzhou Infectious Disease Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Xuzhou Infectious Disease Hospital, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".